Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002.
Multiple genetic alterations such as in Ras or EGFR can result in sustained signaling through PI3K. Our previous experiments have shown that resistance to radiation results from PI3K activity in cells in culture. Here we examined whether inhibition of PI3K in vivo would sensitize tumors to radiation...
Huvudupphovsmän: | Gupta, A, Cerniglia, G, Mick, R, Ahmed, MS, Bakanauskas, V, Muschel, R, Mckenna, W |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
2003
|
Liknande verk
Liknande verk
-
Inhibition of LY294002 in retinal neovascularization via down-regulation the PI3K/AKT-VEGF pathway in vivo and in vitro
av: Yu Di, et al.
Publicerad: (2018-08-01) -
Encapsulation of PI3K Inhibitor LY294002 within Polymer Nanoparticles Using Ion Pairing Flash Nanoprecipitation
av: Austin D. Fergusson, et al.
Publicerad: (2023-04-01) -
Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells
av: Masaki Tsutomu, et al.
Publicerad: (2008-11-01) -
Effects of LY294002 on the function of retinal endothelial cell in vitro
av: Yu Di, et al.
Publicerad: (2018-09-01) -
Phosphatidylinositol 3-kinase inhibitor(LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo
av: Zhou Gengyin, et al.
Publicerad: (2010-04-01)